Outcome

Hyperbaric Oxygen Therapy (HBO) demonstrates significant benefits in treating spinal cord injuries (SCI) by mitigating secondary damage primarily through the reduction of inflammatory responses. The study indicates that HBO effectively decreases the expression levels of key inflammatory markers HMGB1 and NF-κB particularly noted at days 7 and 14 post-injury.

Introduction

Spinal cord injury (SCI) often leads to secondary damage characterized by inflammation and neurological impairment. Hyperbaric Oxygen Therapy (HBO) has emerged as a potential treatment modality to alleviate these secondary effects by modulating inflammatory responses. This study investigates the impact of HBO on key inflammatory markers namely high-mobility group protein B1 (HMGB1) and nuclear factor κB (NF-κB) which are known to exacerbate secondary injury post-SCI. Findings indicate that HBO therapy significantly reduces the expression of HMGB1 and NF-κB resulting in decreased inflammation and improved neurological function in rat models. Enhanced physical performance as measured by the Basso Beattie and Bresnahan (BBB) score was particularly evident at 7 and 14 days post-treatment. These results suggest that HBO could play a valuable role in managing secondary injury and promoting recovery following SCI by targeting inflammatory pathways.

Results

The study investigated the impact of hyperbaric oxygen therapy (HBO) on spinal cord injury (SCI) in rats focusing on the expression of inflammatory markers HMGB1 and NF-κB and the subsequent neurological recovery. Following SCI induction there was a marked increase in both mRNA and protein levels of HMGB1 and NF-κB compared to the sham group. These elevated levels significantly decreased after HBO treatment. Specifically HMGB1 expression was notably reduced at days 7 and 14 post-HBO treatment while NF-κB levels showed significant decreases at days 3 7 and 14.

The therapeutic efficacy of HBO was also evidenced by improved functional outcomes. The Basso Beattie and Bresnahan (BBB) score a metric for assessing locomotor recovery exhibited significant increases in the SCI + HBO group at days 7 and 14. This improvement in BBB scores indicates enhanced neurological function post-HBO therapy.

Overall these results underscore HBO’s potential in attenuating secondary inflammation and fostering neurological repair in SCI by downregulating HMGB1 and NF-κB. This study suggests that HBO could be a valuable therapeutic approach for managing spinal cord injuries highlighting its role in controlling inflammatory responses and supporting neurological recovery.

Conclusion

In conclusion this study reveals that Hyperbaric Oxygen Therapy (HBO) offers substantial benefits in treating spinal cord injuries (SCI) by mitigating the effects of secondary damage predominantly mediated by inflammatory responses. The significant reduction in HMGB1 and NF-κB expression levels following HBO treatment particularly noticeable at days 7 and 14 post-injury underscores the therapy’s potential in downregulating key inflammatory markers involved in SCI. Additionally the observed improvements in Basso Beattie and Bresnahan (BBB) scores at the same time points indicate enhanced neurological recovery and functional outcomes. These findings suggest that HBO could play a crucial role in managing SCI by controlling the inflammatory response thereby promoting better recovery.

While this study was conducted on a rat model the consistent results lay a promising groundwork for future research in human subjects. Further investigations should explore the optimal treatment pressures and frequencies to maximize therapeutic benefits and better understand HBO’s mechanisms of action. Ultimately these insights suggest that HBO could become a valuable component of post-injury care for SCI patients potentially improving their quality of life through effective inflammation management.